Clinical differences in a multidisciplinary pediatric pain unit between primary and secondary chronic pain

• Published in: Revista española de anestesiología y reanimación (English ed.) 2023-03, Vol.70 (3), p.148-155
• Main Authors: Alonso-Prieto, M., Pujol, D., Angustias Salmerón, M., de-Ceano Vivas-Lacalle, M., Ortiz Villalobos, A., Martínez Moreno, M., González Morán, G., Torres-Luna, R., Miró, J., Reinoso-Barbero, F.
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Analgesics - therapeutic use; Analgesics, Opioid; Analgésicos opiáceos; Child; Child, Preschool; Childhood chronic pain; Chronic Pain - drug therapy; Dolor crónico infantil; Dolor crónico primario; Female; Gabapentinoides; Gabapentinoids; Humans; Male; Multidisciplinary pain management unit; Opioid analgesics; Pain Measurement - methods; Primary chronic pain; Retrospective Studies; Unidad multidisciplinar de tratamiento del dolor; Young Adult
• ISSN: 2341-1929; 2341-1929
• DOI: 10.1016/j.redare.2021.12.004

Chronic pain affects an important part of the pediatric population in developed countries. secondary chronic pain (SCP) can have a well-defined medical cause, but primary chronic pain (PCP) can have an unknown etiology. In Spain, there is as yet no information on the clinical differences between patients treated in multidisciplinary units. Retrospective analysis of the clinical records of patients seen in 2018 at the Children's Chronic Pain Unit in University La Paz Hospital. A total of 92 patients were included, (age between 3 and 19 years), with a mean age of 12.4 (SD = 4.1) years, mostly female (55%), with a mean duration of pain of 11.3 (SD = 10.4) months. A comparison of patients with PCP (n = 31) and SCP (n = 61) showed that both groups, on average, presented intense pain (X = 5.9; SD = 2.2; range = 0−10), with similar duration and functional repercussions, although PCP was less likely to be associated with neuropathic descriptors than SCP (p = 0.040), and was more extensive (p